Asthma-nefrin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 14 USDMF, 4 CEP/COS, 2 JDMF, 4 EU WC, 20 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

114 Drugs in Development

114 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

340 FDF Dossiers, 97 FDA Orange Book, 173 Europe, 17 Canada, 20 Australia, 15 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/DELIVERY, INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.1MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY, SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS - 1MG/ML (1MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML), SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/0.3ML (0.15MG/0.3ML), SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/0.3ML (0.3MG/0.3ML), INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY, INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY, INJECTABLE;INJECTION - 0.005MG/ML;0.5%, INJECTABLE;INJECTION - 0.005MG/ML;1%, INJECTABLE;INJECTION - 0.005MG/ML;1.5%, INJECTABLE;INJECTION - 0.005MG/ML;2%, INJECTABLE;INJECTION - 0.01MG/ML;1%, INJECTABLE;INJECTION - 0.01MG/ML;2%, INJECTABLE;INJECTION - 0.02MG/ML;2%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 1.5%, INJECTABLE;INJECTION - 2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 9 Rochem International Inc, 19 SPI Pharma, 1 DKSH, 1 Pharm-RX Chemical, 6 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 6 Kirsch Pharma, 11 Actylis, 2 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 9 BASF, 8 Beneo, 1 Bioplus Life Sciences, 1 CD Formulation, 2 DFE Pharma, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 2 Ideal Cures, 3 Ingredion Pharma Solutions, 3 Kerry, 1 Keval Exports, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 33 Roquette, 2 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 3 Silverline Chemicals, 1 Symrise, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 40 Taste Masking, 32 Direct Compression, 25 Thickeners and Stabilizers, 24 Chewable & Orodispersible Aids, 23 Disintegrants & Superdisintegrants, 19 Parenteral, 18 Coating Systems & Additives, 17 Film Formers & Plasticizers, 16 Granulation, 14 Lubricants & Glidants, 12 Co-Processed Excipients, 8 Controlled & Modified Release, 8 Solubilizers, 4 Topical, 4 Emulsifying Agents, 2 API Stability Enhancers, 1 Soft Gelatin, 1 Rheology Modifiers

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 500 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 97 Regulatory FDF Prices, 21 Annual Reports

MARKET PLACE

22 APIs, 26 FDF Dossiers

PATENTS & EXCLUSIVITIES

88 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

3 USP, 6 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 6488 / DOSAGE - INJECTABLE;INJECTION - 0.005MG/ML;0.5%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LIDOCAINE HYDROCHLORIDE ANHYDROUS(UNII: EC2CNF7XFP) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE HYDROCHLORIDE ANHYDROUS	5mg in 1

Inactive Ingredients

Ingredient Name	General Injectables & Vaccines, Inc	Cardinal Health	RX PHARMA-PACK, INC.	REMEDYREPACK INC.
ANHYDROUS CITRIC ACID(XF417D3PSL)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
HYDROCHLORIC ACID(QTT17582CB)
METHYLPARABEN(A2I8C7HI9T)
NONOXYNOL-9(48Q180SH9T)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM HYDROXIDE(55X04QC32I)
SODIUM METABISULFITE(4VON5FNS3C)
SODIUM PHOSPHATE, DIBASIC(GR686LBA74)
WATER(059QF0KO0R)

Drug Product Composition: Asthma-nefrin

Asthma-nefrin

Asthma-nefrin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers

14 USDMF

4 CEP/COS

2 JDMF

4 EU WC

20 NDC API

16 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

114 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

340 FDF Dossiers

97 FDA Orange Book

173 Europe

17 Canada

20 Australia

15 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/DELIVERY

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/DELIVERY

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.1MG/DELIVERY

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY

SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML)

SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML)

SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML)

SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS - 1MG/ML (1MG/ML)

SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML)

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/0.3ML (0.15MG/0.3ML)

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/0.3ML (0.3MG/0.3ML)

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY

INJECTABLE;INJECTION - 0.005MG/ML;0.5%

INJECTABLE;INJECTION - 0.005MG/ML;1%

INJECTABLE;INJECTION - 0.005MG/ML;1.5%

INJECTABLE;INJECTION - 0.005MG/ML;2%

INJECTABLE;INJECTION - 0.01MG/ML;1%

INJECTABLE;INJECTION - 0.01MG/ML;2%

INJECTABLE;INJECTION - 0.02MG/ML;2%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 1%

INJECTABLE;INJECTION - 1.5%

INJECTABLE;INJECTION - 2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

9 Rochem International Inc

19 SPI Pharma

1 DKSH

1 Pharm-RX Chemical

6 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

6 Kirsch Pharma

11 Actylis

2 Alcedo Pharmachem

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

9 BASF

8 Beneo

1 Bioplus Life Sciences

1 CD Formulation

2 DFE Pharma

7 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

2 Ideal Cures

3 Ingredion Pharma Solutions

3 Kerry